Rank #1757XBIO

Xenetic Biosciences, Inc.

$2.28

-2.98% (Daily)

Market Cap

$5.22M

Revenue

$2.86M

Rank by MCap

#1757

Sector

Healthcare

Industry

Biotechnology

CEO

Mr. James F. Parslow

Headquarters

Framingham, MA

Employees

About Xenetic Biosciences, Inc.

Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing immune-oncology technologies to treat cancers. The company's proprietary DNase platform is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in cancer progression, pancreatic ductal adenocarcinoma, colorectal carcinoma, and other gastrointestinal cancer. Its product pipeline includes XBIO-015 for treating pancreatic c...